XML 41 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Business Segment Information
 12 Months Ended
Mar. 31, 2019
Notes To Financial Statements [Abstract]  
Business Segment Information .
Our Healthcare Products segment offers infection prevention and procedural solutions for healthcare providers worldwide, including consumable products, equipment maintenance and installation services, and capital equipment.
Our Healthcare Specialty Services segment provides a range of specialty services for healthcare providers including hospital sterilization services and instrument and scope repairs. Linen Management Services were divested in fiscal 2017.
Our Life Sciences segment offers consumable products, equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and capital equipment.
Our Applied Sterilization Technologies segment offers contract sterilization and laboratory services for medical device and pharmaceutical Customers and others.
We disclose a measure of segment income that is consistent with the way management operates and views the business. The accounting policies for reportable segments are the same as those for the consolidated Company. In fiscal 2019, we ceased the allocation of certain corporate costs to our segments to align with internal management measures. The prior period operating income measures have been recast for comparability.
For the year ended March 31, 2019, revenues from a single Customer did not represent ten percent or more of any reportable segment’s revenues.

Years Ended March 31,
 
2019
 
2018
 
2017
Revenues:
 
 
 
 
 
 
Healthcare Products
 
$
1,338,428

 
$
1,276,054

 
$
1,266,517

Healthcare Specialty Services
 
510,057

 
469,065

 
539,536

Life Sciences
 
378,558

 
361,590

 
328,866

Applied Sterilization Technologies
 
555,127

 
513,287

 
477,837

Total revenues
 
$
2,782,170

 
$
2,619,996

 
$
2,612,756

Operating income (loss):
 
 
 
 
 
 
Healthcare Products
 
323,684

 
294,162

 
285,177

Healthcare Specialty Services
 
64,222

 
58,458

 
41,019

Life Sciences
 
132,129

 
123,889

 
109,953

Applied Sterilization Technologies
 
221,828

 
196,297

 
176,397

Total reportable segments
 
741,863

 
672,806

 
612,546

Corporate
 
(184,900
)

(162,999
)
 
(137,403
)
Total operating income before adjustments
 
$
556,963

 
$
509,807

 
$
475,143

Less: Adjustments
 
 
 
 
 
 
Goodwill impairment loss (1)
 
—

 
—

 
58,356

Amortization of inventory and property "step up" to
fair value (2)
 
2,440

 
1,599

 
4,743

Amortization of acquired intangible assets (2)
 
86,878

 
67,793

 
66,398

Acquisition and integration related transaction charges (3)
 
8,901

 
16,211

 
30,082

(Gain) loss on fair value adjustment of acquisition related contingent consideration
 
(842
)
 
(593
)
 
2,569

Net (gain) loss on divestiture of businesses (2)
 
(1,370
)
 
14,547

 
86,574

Impact of the U.S. Tax Cuts and Jobs Act (4) 
 
—

 
10,264

 
—

Redomiciliation costs (5)
 
8,783

 
—

 
—

Restructuring charges (6)
 
40,708

 
103

 
215

Total operating income
 
$
411,465

 
$
399,883

 
$
226,206


(1) For more information regarding our goodwill impairment loss see Note 3 titled, "Goodwill and Intangible Assets".
(2) For more information regarding our recent acquisitions and divestitures see Note 18 titled, "Business Acquisitions and Divestitures". Amortization of purchased intangible assets fiscal 2019 total includes an impairment charge of $16,249, see Note 3 titled, "Goodwill and Intangible Assets", for more information.
(3) Acquisition and integration related charges include transaction costs and integration expenses associated with acquisitions.
(4) Represents a one-time special employee bonus paid to most U.S. employees and associated professional fees.
(5) Costs incurred in connection with the decision to redomicile.
(6) See Note 2 titled, "Restructuring", for more information.
Assets include the current and long-lived assets directly attributable to the segment based on the management of the location or on utilization. Certain corporate assets were allocated to the reportable segments based on revenues. Assets attributed to sales and distribution locations are only allocated to the Healthcare Products and Life Sciences segments.
Individual facilities, equipment, and intellectual properties are utilized for production by both the Healthcare Products and Life Sciences segments at varying levels over time. As a result, an allocation of total assets, capital expenditures, and depreciation and amortization is not meaningful to the individual performance of the Healthcare Products and Life Sciences segments. Therefore, their respective amounts are reported together.
March 31,
 
2019
 
2018
Assets:
 
 
 
 
Healthcare Products and Life Sciences
 
$
1,611,852

 
$
1,621,156

Healthcare Specialty Services
 
805,349

 
813,909

Applied Sterilization Technologies
 
2,655,870

 
2,765,269

Total assets
 
$
5,073,071

 
$
5,200,334


Years Ended March 31,
 
2019
 
2018
 
2017
Capital Expenditures
 
 
 
 
 
 
Healthcare Products and Life Sciences
 
$
49,688

 
$
52,767

 
$
39,253

Healthcare Specialty Services
 
39,950

 
16,497

 
42,408

Applied Sterilization Technologies
 
100,077

 
96,193

 
91,240

Total Capital Expenditures
 
$
189,715

 
$
165,457

 
$
172,901

Depreciation, Depletion, and Amortization
 
 
 
 
 
 
Healthcare Products and Life Sciences (1)
 
$
81,264

 
$
52,025

 
$
46,709

Healthcare Specialty Services
 
33,392

 
29,269

 
56,860

Applied Sterilization Technologies (1)
 
111,265

 
97,038

 
84,573

Total Depreciation, Depletion, and Amortization
 
$
225,921

 
$
178,332

 
$
188,142

(1) The fiscal 2019 totals include the impact of Restructuring and an impairment charge. See Note 2 titled, "Restructuring" and Note 3 titled, "Goodwill and Intangible Assets", for additional information.
Financial information for each of our United States and international geographic areas is presented in the following table. Revenues are based on the location of these operations and their Customers. Property, plant and equipment, net are those assets that are identified within the operations in each geographic area.
March 31,
 
2019
 
2018
Property, Plant, and Equipment, Net
 
 
 
 
Ireland
 
$
41,137

 
$
38,946

United States
 
577,113

 
530,591

Other locations
 
413,332

 
440,987

Property, Plant, and Equipment, Net
 
$
1,031,582

 
$
1,010,524


Years Ended March 31,
 
2019
 
2018
 
2017
Revenues:
 
 
 
 
 
 
Ireland
 
$
56,784

 
$
48,246

 
$
42,733

United States
 
1,976,814

 
1,836,414

 
1,803,457

Other locations
 
748,572

 
735,336

 
766,566

Total Revenues
 
$
2,782,170

 
$
2,619,996

 
$
2,612,756







Years Ended March 31,
 
2019
 
2018
 
2017
Healthcare Products:
 
 
 
 
 
 
Capital equipment
 
$
568,811

 
527,402
 
549,238
Consumables
 
414,969

 
412,495
 
403,747
Service
 
354,648

 
336,157

 
313,532

Total Healthcare Products Revenues
 
$
1,338,428

 
$
1,276,054

 
$
1,266,517

Total Healthcare Specialty Services Revenues
 
$
510,057

 
$
469,065

 
$
539,536

Life Sciences:
 
 
 
 
 
 
Capital equipment

 
$
102,714

 
100,555
 
84,069
Consumables
 
161,780

 
150,656
 
143,143
Service
 
114,064

 
110,379
 
101,654
Total Life Sciences Revenues
 
$
378,558

 
$
361,590

 
$
328,866

Applied Sterilization Technologies Service Revenues
 
$
555,127

 
$
513,287

 
$
477,837

Total Revenues
 
$
2,782,170

 
$
2,619,996

 
$
2,612,756